Since we launched the Foundation in 2011 we have invested more than 1.5 million euros in research.

We partner with academia, industry and non-profit organizations to accelerate the development of new treatments for Dravet síndrome. Our projects range from diagnostics to drug discovery, preclinical and clinical research.

List of research partners and projects:

Completed Ongoing

	Brain imaging in Dravet síndrome
	Intracellular trafficking of Nav1.1 mutant proteins
	Endocannabinoid system in Dravet syndrome
	Developmed of A1783V Scn1a (conditional knock-in) Dravet mouse model and distribution among the Dravet community***
	Spanish and European Dravet síndrome population estimates
	Characterization of the European population with Dravet síndrome
	Cannabidiol in Epilepsy European meeting
	The Future of Refractory Epilepsy Syndromes, European meeting
	Research on genetic-basis and genetic-modifiers
	Screening of repurposing libraries on zebrafish Dravet model*,**
	Development of cognition assays using zebrafish Dravet model*,**
	Development of cognition clinical biomarkers
	Early genetic diagnosis for Dravet syndrome
	High content screening of repurposing libraries for Nav1.1 and Nav1.6 modulators*
	Characterization of A1783V Dravet mouse model to set up a mouse testing service***
	Characterization of A1783V Dravet mouse model
	Development of electronic Patient-Reported Outcomes (ePRO)

* co-financed by the Swiss Dravet Syndrome Association
** co-financed by the German Dravet Syndrome Association
*** co-financed by the Dravet Syndrome European Federation